Drug Sensitivity
Showing 1 - 25 of >10,000
Colo-rectal Cancer Trial in Beijing (adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro)
Recruiting
- Colo-rectal Cancer
- adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro
-
Beijing, China/Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medici
Aug 4, 2023
Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of
Not yet recruiting
- Organoids
- +2 more
- Biopsy
- (no location specified)
Nov 24, 2023
Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity
Recruiting
- Muscle-Invasive Bladder Carcinoma
- Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Mar 11, 2023
Pancreatic Cancer, Gastric Cancer Trial in Hangzhou (Biopsy of tumor tissue for organoid culture)
Recruiting
- Pancreatic Cancer
- Gastric Cancer
- Biopsy of tumor tissue for organoid culture
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of med
Apr 22, 2023
Advanced Pancreatic Cancer Trial in Shanghai (Chemotherapy guided by organoid drug sensitivity test)
Recruiting
- Advanced Pancreatic Cancer
- Chemotherapy guided by organoid drug sensitivity test
-
Shanghai, ChinaChanghai Hospital
Jul 29, 2022
Pancreatic Cancer Trial in Shanghai (Adjuvant chemo guided by organoid drug sensitivity test)
Recruiting
- Pancreatic Cancer
- Adjuvant chemotherapy guided by organoid drug sensitivity test
-
Shanghai, ChinaChanghai Hospital
Jul 29, 2022
Drug Sensitivity of Patient-Derived Organoid Model From
Recruiting
- Cholangiocarcinoma
- No interventions.
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 29, 2022
Drug Sensitivity and Mutation Profiling
Recruiting
- Ewing Sarcoma
- +6 more
-
Miami, FloridaNicklaus Children's Hospital
Aug 5, 2022
Colon Cancer, Rectal Cancer, Chemo Effect Trial in Beijing (5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil
Recruiting
- Colon Cancer
- +4 more
- 5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil + formyltetrahydrofolate/Irinotecan + 5-fluorouracil + formyltetrahydrofolate/Cetuximab + 5-fluorouracil + formyltetrahydrofolate
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 15, 2022
Brain Slice Explants to Predict Drug Response in Brain Tumors
Not yet recruiting
- Central Nervous System Tumor
- Biospecimen collection
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Jul 28, 2023
Refractory Cancer, Relapsed Cancer Trial in Weston (Drug Sensitivity Test (DST))
Not yet recruiting
- Refractory Cancer
- Relapsed Cancer
- Drug Sensitivity Test (DST)
-
Weston, FloridaLerner College of Medicine: Cleveland Clinic Florida
Sep 1, 2023
3D Bioprinting for Personalized Treatment in Pancreatic Ductal
Recruiting
- Pancreatic Ductal Adenocarcinoma
-
Beijing, Beijing, China
- +1 more
Jul 12, 2023
Analysing Tissue From Metastatic Pancreatic Cancer for Drug
Recruiting
- Metastatic Pancreatic Cancer
- Inditreat
- Experimental drug
-
Vejle, DenmarkDepartmen of Oncology, Vejle Hospital
Apr 26, 2022
Lung Cancer, Organoid, NSCLC Trial in Wuxi (Antitumor therapy guided by organoid drug sensitivity test)
Recruiting
- Lung Cancer
- +2 more
- Antitumor therapy guided by organoid drug sensitivity test
-
Wuxi, Jiangsu, ChinaAffiliated Hospital of Jiangnan University
Feb 2, 2023
HER2-negative Early Breast Cancer Trial in Beijing (neoadjuvant chemo upon in vitro PTC drug sensitivity screening for triple
Recruiting
- HER2-negative Early Breast Cancer
- neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for triple negative breast cancer
- neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for luminal like breast cancer
-
Beijing, ChinaPeking University People's Hospital
Mar 27, 2022
Myeloproliferative Disorders, Lymphoproliferative Disorders Trial in Pierre-Bénite (Blood collection for the evaluation of the
Not yet recruiting
- Myeloproliferative Disorders
- Lymphoproliferative Disorders
- Blood collection for the evaluation of the anti-drugs sensitivity
-
Pierre-Bénite, France
- +1 more
Mar 2, 2022
Breast Cancer Trial in United States (KIBUR MICRODEVICE, anthracycline and taxane based chemo)
Active, not recruiting
- Breast Cancer
- KIBUR MICRODEVICE
- anthracycline and taxane based chemotherapy
-
Basking Ridge, New Jersey
- +5 more
Jun 20, 2022
Metastatic Colorectal Cancer Trial in Oslo (Alectinib, Cetuximab, Crizotinib)
Recruiting
- Metastatic Colorectal Cancer
- Alectinib
- +16 more
-
Oslo, NorwayOslo University Hospital
Feb 10, 2023
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Completed
- Recurrent Childhood Acute Myeloid Leukemia
- +13 more
-
Miami, FloridaNicklaus Children's Hospital
Jan 18, 2023
Multi-Platform Profiling of Resected Biliary Tract Cancer
Recruiting
- Biliary Tract Cancer
- +7 more
- Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
-
Chicago, Illinois
- +1 more
Jan 23, 2023
Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in
Completed
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Chemosensitivity Assay
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 29, 2022
KM3D Multicenter Cancer Consortium: Predicting Patient Response
Recruiting
- Cancer
- +2 more
- Known 3Dx Test
-
Durham, North Carolina
- +1 more
Apr 18, 2022
Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit
Not yet recruiting
- Helicobacter Pylori Infection
- +3 more
- Detection of fecal samples with diagnostic kit
- +2 more
- (no location specified)
Jun 5, 2022
Neoadjuvant Therapy Trial (standard long-term therapy, FOLFOX and standard long-term radiotherapy, FOLFIRI and standard
Not yet recruiting
- Neoadjuvant Therapy
- standard long-term therapy
- +5 more
- (no location specified)
Apr 22, 2022